October 5, 2024 · STOCK Act disclosure
Representative Byron Donalds (Republican-FL) bought Regeneron Pharmaceuticals, Inc., a stock transaction, valued at $1,001 - $15,000. The trade took place on October 5, 2024 and was disclosed on November 8, 2024 (owner: Self). Members of Congress must report such transactions within 45 days under the STOCK Act.